Optimizing drug exposure to minimize selection of antibiotic resistance.
about
When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transitionApplication of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionPharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerCan we prevent antimicrobial resistance by using antimicrobials better?"One-size-fits-all"? Optimizing treatment duration for bacterial infectionsIntegrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentDoes High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?Cancer in light of experimental evolutionScreening and treating Helicobacter pylori infection for gastric cancer prevention on the population level.Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.Emergence and spread of antibiotic resistance: setting a parameter space.Antimicrobial drug use in food-producing animals and associated human health risks: what, and how strong, is the evidence?Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamicsAssessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study.Ciprofloxacin dosage and emergence of resistance in human commensal bacteriaIntegrated pharmacokinetics/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistanceResistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditions.Expert review of the evidence base for self-therapy of travelers' diarrhea.Integration of PK/PD for dose optimization of Cefquinome against Staphylococcus aureus causing septicemia in cattle.Is selection relevant in the evolutionary emergence of drug resistance?Residues of chlortetracycline, doxycycline and sulfadiazine-trimethoprim in intestinal content and feces of pigs due to cross-contamination of feedTriple therapy versus sequential therapy for the first-line Helicobacter pylori eradicationEmerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis.Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.Adaptive resistance to antibiotics in bacteria: a systems biology perspective.Determination of minimum biofilm eradication concentrations of orbifloxacin for canine bacterial uropathogens over different treatment periods.Antibiotic combinations for controlling colistin-resistant Enterobacter cloacae.Evolution of glyphosate resistance in a Lolium rigidum population by glyphosate selection at sublethal doses.Acute myeloid leukemia and the infectious diseases consultant.Postantibiotic Effect and Postantibiotic Sub-MIC Effect of LTX-109 and mupirocin on Staphylococcus aureus Blood Isolates.Studying the effect of administration route and treatment dose on the selection of enrofloxacin resistance in commensal Escherichia coli in broilers.Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin.Perturbation of iron homeostasis promotes the evolution of antibiotic resistance.Evaluation of anti-infective potential of a tribal folklore Odina wodier Roxb against some selected microbes and herpes simplex virus associated with skin infection.Diversity and evolution of drug resistance mechanisms in Mycobacterium tuberculosis.Human Lysozyme Synergistically Enhances Bactericidal Dynamics and Lowers the Resistant Mutant Prevention Concentration for Metronidazole to Helicobacter pylori by Increasing Cell Permeability.[Bacterial sepsis : Diagnostics and calculated antibiotic therapy].Fosfomycin efficacy and emergence of resistance among Enterobacteriaceae in an in vitro dynamic bladder infection model.
P2860
Q21145725-BB110095-5597-4098-87DB-6E44375A5F92Q26753831-7FD77D0C-1E6A-43EC-B396-758556B95CF5Q26825326-7D5BBD4B-DD2C-4149-AD5F-D3D02D76CCC1Q26829707-8B277CA2-FF09-45C9-BC10-463B28E4C7CEQ28478851-54190C10-6B3A-4871-97D3-5E716AFDAEC6Q28551361-9D134A6F-5D68-43C9-82BE-9D8064EAC73FQ28552950-EA60E82C-0F6A-42F6-9E88-A346B6C05EE4Q28727500-4EEC7AD6-22AB-4D49-8282-DB7608F6C207Q30239019-9246B2B3-B6DF-4F57-8A2E-20F49C9EB4E8Q30911044-9E51E4CE-97FD-4B85-A623-35C547546EE1Q33667581-EBCE4F45-3137-4A2C-9116-640972BDB258Q33870110-9C0B08DD-B418-4D01-93E4-F84AC9F1FBE0Q33876556-F97E603D-DB2F-4C60-BD71-F4C89A3B016EQ33925668-F5CCC193-E039-468A-A255-8D502FA58B81Q34104262-806254BA-5035-44E0-8FB6-7F841F8C7650Q34783696-E6FACCC9-C146-404A-8F45-7AAE0B2C0600Q34921154-3B5C8B30-9CF7-4B9A-8CA7-3FD1520E649DQ34987675-4DF46847-5E8F-4802-9EF2-1088EFC45EE1Q35750265-7A3B91CB-57E9-4E0A-B36D-3F936E566213Q35826386-A5B5E6A5-06BE-489D-A281-C28625CE6E6CQ36137477-9D68A11D-4083-4A2C-915E-19A754CD53EBQ36256381-D7EC1F02-37F8-4514-B0CE-442C3D7CF30DQ37125014-3FC97A09-B591-48D8-8E30-FCEDB21BD4B9Q38375170-E4C7D9FC-22B9-46B3-928F-EC8A98690301Q38814607-A852E19F-1F8E-4F3B-A712-10A9D3FBE5CAQ39044604-F99DB947-56B0-46EE-828A-52E00FAD81B6Q39629148-31E7D5FB-9BE9-4780-B98B-621388901858Q39974195-AF23300B-617B-40B7-BC12-342E8A42307EQ40039262-5F1040ED-5DAF-4818-A556-C761B68FA1C7Q40096314-68140EC0-854C-4EA9-8CA1-4D6F2BCC31E8Q40238353-CEFFD00D-E2D0-4B69-BC3A-87517715AADDQ40499211-3BB8AD03-B9EF-4A74-BEEF-645647CF4D84Q40906422-8E5A1814-C0C0-4E70-BF18-815279F0CBE3Q41648730-6F5B2533-5F98-43ED-A744-4099D3D3AA86Q42022178-E2B18F35-A704-4A1D-A996-05FFBF64B31BQ42275774-D4C91658-4131-4EC2-BE14-01594E5C6926Q42673180-4D743012-DD99-45CD-ADD6-E19C7C23DB89Q48948199-B12D0A62-9D15-4757-986A-5664E877479BQ49589601-CF2C30C3-9C62-4AF2-B1BE-428A1CEDF8A2Q49667957-9AA47CD5-E92F-49FB-A847-13FB8EF808A4
P2860
Optimizing drug exposure to minimize selection of antibiotic resistance.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Optimizing drug exposure to minimize selection of antibiotic resistance.
@en
type
label
Optimizing drug exposure to minimize selection of antibiotic resistance.
@en
prefLabel
Optimizing drug exposure to minimize selection of antibiotic resistance.
@en
P2860
P356
P1476
Optimizing drug exposure to minimize selection of antibiotic resistance.
@en
P2093
Sara K Olofsson
P2860
P304
P356
10.1086/519256
P407
P478
45 Suppl 2
P577
2007-09-01T00:00:00Z